Preterm birth: Inflammation, fetal injury and treatment strategies

Ashley K Boyle1, Sara F Rinaldi1, Jane E Norman1

  • 1Tommy's Centre for Maternal and Fetal Health at the Medical Research Council Centre for Reproductive Health, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, United Kingdom.

Insights

Preterm birth (PTB), a major cause of infant mortality, is often linked to intrauterine infection and inflammation. This review explores inflammation

Area of Science:

  • Reproductive Medicine
  • Neonatal Health
  • Inflammatory Biology

Background:

  • Preterm birth (PTB) is a global health concern, causing significant childhood mortality and long-term complications like cerebral palsy.
  • Spontaneous PTB is frequently associated with intrauterine infection and inflammation, impacting fetal development.
  • Inflammatory mediators in utero can lead to fetal injury, particularly affecting the brain and lungs.

Purpose of the Study:

  • To review the role of inflammation in both term and preterm birth.
  • To examine the impact of intrauterine infection/inflammation on fetal development.
  • To discuss current and emerging strategies for targeting and preventing PTB.

Main Methods:

  • Literature review focusing on the relationship between inflammation, infection, and preterm birth.
  • Analysis of studies investigating fetal injury mechanisms related to intrauterine inflammation.
  • Synthesis of recent research on therapeutic and preventative strategies for PTB.

Main Results:

  • Inflammation plays a critical role in the pathophysiology of spontaneous preterm birth.
  • Intrauterine infection and inflammation are linked to adverse fetal outcomes, including neurological and respiratory damage.
  • Current strategies for PTB prevention and treatment are limited, highlighting the need for further research.

Conclusions:

  • Understanding the inflammatory pathways in PTB is crucial for developing effective interventions.
  • Targeting intrauterine inflammation may offer a promising approach to reduce PTB and associated fetal injuries.
  • Urgent research is needed to develop novel methods for PTB prevention, treatment, and mitigation of fetal harm.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
63.3K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
17.6K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
17.7K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
875
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
675
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
777